414 related articles for article (PubMed ID: 19031695)
21. Analysis of recombinant dengue virus polypeptides for dengue diagnosis and evaluation of the humoral immune response.
dos Santos FB; Miagostovich MP; Nogueira RM; Schatzmayr HG; Riley LW; Harris E
Am J Trop Med Hyg; 2004 Aug; 71(2):144-52. PubMed ID: 15306702
[TBL] [Abstract][Full Text] [Related]
22. Production and characterization of recombinant dengue virus type 4 envelope domain III protein.
Tripathi NK; Babu JP; Shrivastva A; Parida M; Jana AM; Rao PV
J Biotechnol; 2008 Apr; 134(3-4):278-86. PubMed ID: 18342971
[TBL] [Abstract][Full Text] [Related]
23. Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.
Tan LC; Chua AJ; Goh LS; Pua SM; Cheong YK; Ng ML
Protein Expr Purif; 2010 Nov; 74(1):129-37. PubMed ID: 20600950
[TBL] [Abstract][Full Text] [Related]
24. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
[TBL] [Abstract][Full Text] [Related]
25. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
26. Recombinant dengue virus type 3 envelope domain III protein from Escherichia coli.
Tripathi NK; Shrivastava A; Biswal KC; Rao PV
Biotechnol J; 2011 May; 6(5):604-8. PubMed ID: 21538895
[TBL] [Abstract][Full Text] [Related]
27. Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.
Batra G; Talha SM; Nemani SK; Dhar N; Swaminathan S; Khanna N
Protein Expr Purif; 2010 Nov; 74(1):99-105. PubMed ID: 20435144
[TBL] [Abstract][Full Text] [Related]
28. Dengue-1 envelope protein domain III produced in Pichia pastoris: potential use for serological diagnosis.
Cardoso SA; Paixão VF; Oliveira MD; Honda ER; Oliveira LL; da Silva CC; De Paula SO
Protein Expr Purif; 2013 Nov; 92(1):9-13. PubMed ID: 23993978
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells.
Huerta V; Chinea G; Fleitas N; Sarría M; Sánchez J; Toledo P; Padrón G
Virus Res; 2008 Nov; 137(2):225-34. PubMed ID: 18723056
[TBL] [Abstract][Full Text] [Related]
30. Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris.
Guzmán MG; Rodríguez R; Rodríguez R; Hermida L; Alvarez M; Lazo L; Muné M; Rosario D; Valdés K; Vázquez S; Martinez R; Serrano T; Paez J; Espinosa R; Pumariega T; Guillén G
Am J Trop Med Hyg; 2003 Aug; 69(2):129-34. PubMed ID: 13677367
[TBL] [Abstract][Full Text] [Related]
31. Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use.
Valdés I; Hermida L; Gil L; Lazo L; Castro J; Martín J; Bernardo L; López C; Niebla O; Menéndez T; Romero Y; Sánchez J; Guzmán MG; Guillén G
Int J Infect Dis; 2010 May; 14(5):e377-83. PubMed ID: 19773190
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
[TBL] [Abstract][Full Text] [Related]
33. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
[TBL] [Abstract][Full Text] [Related]
34. A fragment of the envelope protein from dengue-1 virus, fused in two different sites of the meningococcal P64k protein carrier, induces a functional immune response in mice.
Hermida L; Rodríguez R; Lazo L; Bernardo L; Silva R; Zulueta A; López C; Martín J; Valdés I; del Rosario D; Guillén G; Guzmán MG
Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):107-14. PubMed ID: 12887334
[TBL] [Abstract][Full Text] [Related]
35. Domain III of the envelope protein as a dengue vaccine target.
Guzman MG; Hermida L; Bernardo L; Ramirez R; Guillén G
Expert Rev Vaccines; 2010 Feb; 9(2):137-47. PubMed ID: 20109025
[TBL] [Abstract][Full Text] [Related]
36. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.
Beasley DW; Aaskov JG
Virology; 2001 Jan; 279(2):447-58. PubMed ID: 11162801
[TBL] [Abstract][Full Text] [Related]
37. Production and characterization of anti-dengue capsid antibodies suggesting the N terminus region covering the first 20 amino acids of dengue virus capsid protein is predominantly immunogenic in mice.
Puttikhunt C; Ong-Ajchaowlerd P; Prommool T; Sangiambut S; Netsawang J; Limjindaporn T; Malasit P; Kasinrerk W
Arch Virol; 2009; 154(8):1211-21. PubMed ID: 19565324
[TBL] [Abstract][Full Text] [Related]
38. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent.
AnandaRao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Protein Expr Purif; 2005 May; 41(1):136-47. PubMed ID: 15802231
[TBL] [Abstract][Full Text] [Related]
39. Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity.
Chiang CY; Hsieh CH; Chen MY; Tsai JP; Liu HH; Liu SJ; Chong P; Leng CH; Chen HW
Vaccine; 2014 Mar; 32(12):1346-53. PubMed ID: 24486311
[TBL] [Abstract][Full Text] [Related]
40. Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus.
Puttikhunt C; Keelapang P; Khemnu N; Sittisombut N; Kasinrerk W; Malasit P
J Med Virol; 2008 Jan; 80(1):125-33. PubMed ID: 18041028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
